Who is sponsoring NCT04756349?

NCT04756349 is sponsored by Universidade Federal do Para.

What drugs are being tested in NCT04756349?

Interventions in NCT04756349: composite resin restoration.

What condition does NCT04756349 study?

NCT04756349 studies Non Carious Cervical Lesion.

Is NCT04756349 still recruiting?

NCT04756349 is currently completed. Last updated 24 May 2022.

Last reviewed 2022-05-24 · How we verify

NCT04756349

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Performance of Adhesive Systems Containing HEMA and 10-MDP in Non Carious Cervical Lesions

Completed NA Last updated 24 May 2022

What this trial tests

NA trial testing composite resin restoration in Non Carious Cervical Lesion in 18 participants. Completed in 12 February 2022.

Timeline

12 February 2020

Primary endpoint
12 February 2021

12 February 2022

Quick facts

Lead sponsor	Universidade Federal do Para
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	18
Start date	12 February 2020
Primary completion	12 February 2021
Estimated completion	12 February 2022
Sites	1 location across Brazil

Drugs / interventions tested

composite resin restoration

Conditions studied

Non Carious Cervical Lesion — all drugs for Non Carious Cervical Lesion →

Sponsor

Universidade Federal do Para — full company profile →

Who can join

18 and older, any sex, with Non Carious Cervical Lesion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this randomized, double-blind clinical trial is to evaluate the clinical performance of non-carious cervicals adhesive restorations using three self-etching adhesives containing HEMA and 10-MDP monomers.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Universidade Federal do Para trials

Trials by the same sponsor.

NCT07506850 — Effect of CPP-ACP Associated With NaF or SnF₂ on Post-Bleaching Tooth Sensitivity · NA · completed
NCT06614764 — Effect of Andiroba on Control of Post-whitening Tooth Sensitivity · NA · completed
NCT06872749 — Effect of an Experimental Gel Containing Copaiba Oil-resin in the Control of Dentin Hypersensitivity · NA · completed
NCT06971783 — Effect of an Experimental Gel Based on Acmella Oleracea Extract Associated or Not With Fluoride on Dentin Hypersensitivi · NA · completed
NCT06518629 — Photobiomodulation Before or After Tooth Whitening · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04756349 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universidade Federal do Para
Last refreshed: 24 May 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04756349.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing